http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1020500

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article
endingPage 7
issn 1021-335X
1791-2431
issueIdentifier 5
pageRange 1321-7
publicationName Oncology Reports
startingPage 1321
bibliographicCitation Festuccia C, Gravina G, Muzi P, Biordi L, Ronchi P, Martella O, Vicentini C, Bologna M. Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients. Oncol Rep. 2007 Nov 01;(). doi: 10.3892/or.18.5.1321.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a03ad0f86d2d9a9cfa16136aad274a64
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1adebc5ac1491406641a6ac4538f0e9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a0a4d64252d2824bfc6c8c7aa56baed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8932fd1e09b8cbdd55b4229c0664b98
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0776-0312
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e41d453439e5230da41a97437fd97b38
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13f43c879e2c5a47e7503d0c474387cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73f9da7d517d15e19f08a5537778390f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca6d31f7a0de383d1efc09e590911e73
date 2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/17914592
https://doi.org/10.3892/or.18.5.1321
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20608
https://portal.issn.org/resource/ISSN/1021-335X
https://portal.issn.org/resource/ISSN/1791-2431
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients
discusses http://id.nlm.nih.gov/mesh/M0151653
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0001106
http://id.nlm.nih.gov/mesh/M0014878
http://id.nlm.nih.gov/mesh/M0282104
http://id.nlm.nih.gov/mesh/M0479128
http://id.nlm.nih.gov/mesh/M0001214
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0021712
http://id.nlm.nih.gov/mesh/M0444984
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000494
http://id.nlm.nih.gov/mesh/D011471Q000188
http://id.nlm.nih.gov/mesh/D000728Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004357
http://id.nlm.nih.gov/mesh/D011799Q000008
http://id.nlm.nih.gov/mesh/D045744Q000187
http://id.nlm.nih.gov/mesh/D000077156
http://id.nlm.nih.gov/mesh/D051059Q000378
http://id.nlm.nih.gov/mesh/D000813Q000008
http://id.nlm.nih.gov/mesh/D014105Q000008
http://id.nlm.nih.gov/mesh/D009570Q000008
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018719Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128501763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129153627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229605

Total number of triples: 67.